Related Experiment Video
Updated: Jul 31, 2026
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys
Yi He1, Patricia S Thong, Timothy Lee
1Department of Surgery, National University of Singapore, Singapore, Singapore. yih@bcm.tmc.edu
Abstract:
Though increasing lines of evidence suggest that iron accumulation and iron-induced oxidative stress might be important pathological factors responsible for substantia nigra (SN) cell death in Parkinson's disease (PD), it is still unknown whether iron accumulation is a primary cause or consequence of nigral cell death. Using nuclear microscopy, iron histochemistry, TUNEL method for apoptosis detection, and tyrosine hydroxylase (TH) immunohistochemistry, the present study investigated possible changes in iron contents in the SN and correlations of dopaminergic cell death progression with the process of iron accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian monkey from 1 d to 18 months after MPTP administration. Our study demonstrated that apoptosis occurred in the ipsilateral SN at 1 d after MPTP injection and the number of TH-positive cells decreased significantly from 1 week onward. However, iron content was significantly increased in the ipsilateral SN from 4.5 months to 18 months after MPTP injection, and the iron increase was significantly correlated to the extent of dopaminergic cell death. These results suggest that dopaminergic cell death induced by MPTP administration might lead to iron accumulation in the monkey SN, and increased iron might contribute to the progression of nigral degeneration.
Insights
Parkinson's disease (PD) involves substantia nigra (SN) cell death. This study found that MPTP-induced cell death in monkeys precedes iron accumulation in the SN, suggesting iron accumulation may worsen neurodegeneration.
Area of Science:
- Neuroscience
- Pathology
- Biochemistry
Background:
- Iron accumulation in the substantia nigra (SN) is implicated in Parkinson's disease (PD) pathogenesis.
- The causal relationship between iron accumulation and dopaminergic cell death in PD remains unclear.
Purpose of the Study:
- To investigate the temporal relationship between iron accumulation and dopaminergic cell death in the SN.
- To determine if iron accumulation is a cause or consequence of neurodegeneration in a Parkinson's disease model.
Main Methods:
- Utilized a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.
- Employed nuclear microscopy, iron histochemistry, TUNEL assay for apoptosis, and tyrosine hydroxylase (TH) immunohistochemistry.
- Monitored changes from 1 day to 18 months post-MPTP administration.
Main Results:
- Apoptosis and significant decrease in TH-positive cells were observed in the SN within 1 week of MPTP injection.
- Iron content in the SN significantly increased between 4.5 and 18 months post-MPTP.
- Increased iron levels showed a significant correlation with the extent of dopaminergic cell death.
Conclusions:
- MPTP-induced dopaminergic cell death precedes and correlates with iron accumulation in the primate SN.
- These findings suggest that iron accumulation may be a consequence of, rather than a primary cause for, nigral degeneration in this PD model.
- Increased iron may contribute to the progression of neurodegeneration in Parkinson's disease.
